Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Fulcrum Therapeutics, Inc. | 57,000 | reported | 02 Feb 2026 | tx 12+269,330−5,828 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Feb 2026 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 57,000 | 0.00 USD | deriv |
| 08 May 2025 | SALE | Fulcrum Therapeutics, Inc. | 498 | 5.06 USD | |
| 24 Jan 2025 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 76,120 | 0.00 USD | deriv |
| 07 May 2024 | SALE | Fulcrum Therapeutics, Inc. | 236 | 7.76 USD | |
| 08 Mar 2024 | SALE | Fulcrum Therapeutics, Inc. | 4,884 | 11.72 USD | |
| 26 Jan 2024 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 26 Jan 2024 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 83,820 | 0.00 USD | deriv |
| 10 May 2023 | SALE | Fulcrum Therapeutics, Inc. | 210 | 3.31 USD | |
| 09 Feb 2023 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 16,100 | 0.00 USD | deriv |
| 15 Jul 2022 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 16,540 | 0.00 USD | deriv |
| 06 May 2022 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 3,250 | 0.00 USD | |
| 06 May 2022 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 6,500 | 0.00 USD | deriv |